TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
XCUR

Exicure Inc

Healthcare · Biotechnology

1.20$ -2.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow XCUR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – -3,081.8% – – – – –
– +35.3% +28.9% +54.3% +102.2% +99.9% +22.9% +4.3% -25.9% -40.1% -44.2%
– +84.3% +114.4% +23.7% +1.7% +18.7% +34.6% -53.4% -1.5% -98.4% -90.9%
– – +66.6% +99.0% -40.0% +24.4% +68.1% -54.9% – – –
– +2,314.6% -197.0% – – -172.7% – -252.7% – -31.0% +81.0%
– +3,183.3% +135.0% -89.8% +1,051.1% +193.1% -69.5% -99.0% -100.0% – –
– +3,183.3% +135.0% -89.8% +67,380.9% – +324.8% -89.1% -123.0% – –
– -97.6% +6,433.3% -30.1% +312.1% -96.3% -100.4% -71.4% +19,900.0% – –
– +0.0% -116.7% – +0.0% -4.0% -183.4% -25.0% -100.0% – -100.0%
– -67.7% +323.9% -25.2% +319.8% -82.1% -92.6% -378.2% – +264.8% -88.1%
– -87.9% +588.5% -91.8% +4,303.2% -163.1% – -463.1% – – -183.5%
– – – – – -18,160.0% – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?